Karp JE - Search Results

1

Metabolic and electrochemical mechanisms of dimeric naphthoquinones cytotoxicity in breast cancer cells.

Emadi A, Le A, Harwood CJ, Stagliano KW, Kamangar F, Ross AE, Cooper CR, Dang CV, Karp JE, Vuica-Ross M. Emadi A, et al. Among authors: karp je. Bioorg Med Chem. 2011 Dec 1;19(23):7057-62. doi: 10.1016/j.bmc.2011.10.005. Epub 2011 Oct 8. Bioorg Med Chem. 2011. PMID: 22036210 Free PMC article.

2

The clinically relevant pharmacogenomic changes in acute myelogenous leukemia.

Emadi A, Karp JE. Emadi A, et al. Among authors: karp je. Pharmacogenomics. 2012 Aug;13(11):1257-69. doi: 10.2217/pgs.12.102. Pharmacogenomics. 2012. PMID: 22920396 Free PMC article. Review.

3

CD30 in myeloid malignancies: hitting the bull's-eye with an available dart.

Emadi A, Karp JE. Emadi A, et al. Among authors: karp je. Leuk Lymphoma. 2013 Apr;54(4):679-80. doi: 10.3109/10428194.2012.728703. Epub 2012 Sep 28. Leuk Lymphoma. 2013. PMID: 22966972 No abstract available.

4

The state of the union on treatment of acute myeloid leukemia.

Emadi A, Karp JE. Emadi A, et al. Among authors: karp je. Leuk Lymphoma. 2014 Nov;55(11):2423-5. doi: 10.3109/10428194.2014.897705. Epub 2014 Mar 25. Leuk Lymphoma. 2014. PMID: 24576164 No abstract available.

5

Sorafenib is tolerable and improves clinical outcomes in patients with FLT3-ITD acute myeloid leukemia prior to stem cell transplant and after relapse post-transplant.

Sammons SL, Pratz KW, Smith BD, Karp JE, Emadi A. Sammons SL, et al. Among authors: karp je. Am J Hematol. 2014 Sep;89(9):936-8. doi: 10.1002/ajh.23782. Epub 2014 Jun 23. Am J Hematol. 2014. PMID: 24898801 Free PMC article. No abstract available.

6

Elevated lactate dehydrogenase (LDH) can be a marker of immune suppression in cancer: Interplay between hematologic and solid neoplastic clones and their microenvironments.

Ding J, Karp JE, Emadi A. Ding J, et al. Among authors: karp je. Cancer Biomark. 2017 Jul 4;19(4):353-363. doi: 10.3233/CBM-160336. Cancer Biomark. 2017. PMID: 28582845 Review.

7

A Prospective Study of Peritransplant Sorafenib for Patients with FLT3-ITD Acute Myeloid Leukemia Undergoing Allogeneic Transplantation.

Pratz KW, Rudek MA, Smith BD, Karp J, Gojo I, Dezern A, Jones RJ, Greer J, Gocke C, Baer MR, Duong VH, Rosner G, Zahurak M, Wright JJ, Emadi A, Levis M; ETCTN-8922 study team. Pratz KW, et al. Biol Blood Marrow Transplant. 2020 Feb;26(2):300-306. doi: 10.1016/j.bbmt.2019.09.023. Epub 2019 Sep 21. Biol Blood Marrow Transplant. 2020. PMID: 31550496 Free PMC article.

8

Recent drug approvals for newly diagnosed acute myeloid leukemia: gifts or a Trojan horse?

Estey E, Karp JE, Emadi A, Othus M, Gale RP. Estey E, et al. Among authors: karp je. Leukemia. 2020 Mar;34(3):671-681. doi: 10.1038/s41375-019-0704-5. Epub 2020 Jan 8. Leukemia. 2020. PMID: 31915366 Review.

9

Quantitative analysis of breast cancer resistance protein and cellular resistance to flavopiridol in acute leukemia patients.

Nakanishi T, Karp JE, Tan M, Doyle LA, Peters T, Yang W, Wei D, Ross DD. Nakanishi T, et al. Among authors: karp je. Clin Cancer Res. 2003 Aug 15;9(9):3320-8. Clin Cancer Res. 2003. PMID: 12960118

10

Plasma inhibitory activity (PIA): a pharmacodynamic assay reveals insights into the basis for cytotoxic response to FLT3 inhibitors.

Levis M, Brown P, Smith BD, Stine A, Pham R, Stone R, Deangelo D, Galinsky I, Giles F, Estey E, Kantarjian H, Cohen P, Wang Y, Roesel J, Karp JE, Small D. Levis M, et al. Among authors: karp je. Blood. 2006 Nov 15;108(10):3477-83. doi: 10.1182/blood-2006-04-015743. Epub 2006 Jul 20. Blood. 2006. PMID: 16857987 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

290 results

Search Page

Filters